Switching to the extended half-life therapy Elocta, sold in the U.S. as Eloctate, improved control of bleeds among hemophilia ...

The Rare Rewritten campaign hopes to change a misconception about women with X-linked disorders, columnist G Shellye Horowitz ...

Alhemo’s expanded approval drew on explorer8, a Phase 3 study that enrolled about 150 hemophilia A or B patients, who didn't ...

Columnist Allyx Formalejo says that due to ADHD, her tendency to be hyperfocused and need to "help" is really a need for ...

As someone with von Willebrand disease, columnist Jennifer Lynne hopes that trials for VGA039 could lead to a long-sought new treatment.

Columnist Joe MacDonald, who has essential tremors, shares with his sons the feeling of having a sometimes visible disorder.

Columnist Jennifer Lynne shares what it's like to be a woman living with hemophilia — things she wishes doctors would know about the disorder.

Hemophilia treatment can increase life expectancy. Treatment options include factor replacement therapies, bypassing agents, gene therapy.

Marisa Wexler is a senior science writer for Hemophilia News Today with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of hemophilia topics.